Applied DNA Sciences rebrands to BNB Plus Corp., ticker BNBX

Rhea-AI Filing Summary

BNB Plus Corp., formerly Applied DNA Sciences, Inc., has officially changed its corporate name effective November 13, 2025, through an amendment to its certificate of incorporation filed in Delaware. The company states that this name change does not affect the rights of its stockholders. Its common stock now trades on The Nasdaq Stock Market under the symbol BNBX, continuing with the same class of common shares and par value. A press release announcing the new name was issued on November 17, 2025 and is provided as an exhibit for additional context.

8-K Event Classification

3 items: 5.03, 7.01, 9.01

3 items

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance

The company amended its charter documents, bylaws, or changed its fiscal year.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 11/17/2025 - 04:36 PM Learn about SEC filing dates

FAQ

What did Applied DNA Sciences, Inc. (APDN) announce in this 8-K?

The company announced it has changed its corporate name from Applied DNA Sciences, Inc. to BNB Plus Corp., effective November 13, 2025, via an amendment to its certificate of incorporation.

Does the BNB Plus Corp. (BNBX) name change affect stockholder rights?

The company states that the name change does not affect the rights of its stockholders. Only the corporate name has been amended; stockholder rights remain the same.

What is the new Nasdaq trading symbol for BNB Plus Corp.?

The company’s common stock continues to be listed on The Nasdaq Stock Market and now trades under the ticker symbol BNBX.

Was a stockholder vote required for the BNB Plus Corp. name change?

No stockholder vote was required. Under the Delaware General Corporation Law, the board of directors was able to approve and implement the name change without a stockholder vote.

When did BNB Plus Corp. announce the name change publicly?

The company issued a press release on November 17, 2025 announcing the name change, which is furnished as Exhibit 99.1.

Which exhibits are included with this BNB Plus Corp. 8-K filing?

The filing includes a Certificate of Amendment as Exhibit 3.1, the press release dated November 17, 2025 as Exhibit 99.1, and the Cover Page Interactive Data File as Exhibit 104.

false --09-30 0000744452 0000744452 2025-11-13 2025-11-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 13, 2025

BNB Plus Corp.

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation or organization) 001-36745 (Commission File Number) 59-2262718 (IRS Employer Identification No.)

50 Health Sciences Drive

Stony Brook, New York 11790

(Address of principal executive office) (Zip Code)

631-240-8800

(Registrants’ telephone number, including area code)

Applied DNA Sciences, Inc.

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.001 par value		BNBX		The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

Emerging Growth Company    ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

Effective November 13, 2025, Applied DNA Sciences, Inc. (the “Company”) changed its name to BNB Plus Corp., pursuant to an amendment to its amended and restated certificate of incorporation adopted by the Company’s Board of Directors and filed with the Secretary of State of the State of Delaware (the “Name Change”). Pursuant to the Delaware General Corporation Law, a stockholder vote was not necessary to effectuate the Name Change and it does not affect the rights of the Company’s stockholders.

The foregoing description of the amendment to the Company’s amended and restated certificate of incorporation does not purport to be complete and is qualified in its entirety by reference to the full text of the certificate of amendment, which is attached to this Current Report on Form 8-K as Exhibit 3.1 and is incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

On November 17, 2025, the Company issued a press release announcing the Name Change. The press release is furnished with this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

The information in this item, including Exhibit 99.1, is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Exhibit Title
3.1		Certificate of Amendment.
99.1		Press release, dated November 17, 2025.
104		Cover Page Interactive Data File (formatted as inline XBRL).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	BNB PLUS CORP.
Dated: November 17, 2025	By:	/s/ Clay Shorrock
	Name:	Clay Shorrock
	Title:	Chief Executive Officer